Global Supply Chain Recovery Dependent On A Vaccine
Supply Chain Shaman
APRIL 30, 2020
Glaxo SmithKline introduced Shingrix in 2017, but shortages prevailed. The global economy rebound from COVID-19 hinges on the discovery and manufacture of an effective vaccine. The companies are just not good at managing inventories and orchestrating distribution strategies. My left arm hurts. I replied, “Isn’t it all the same?”
367 
Let's personalize your content